PAVmed Inc. Warrant
PAVMW
PAVMW was delisted on the 28th of January, 2022.
2 hedge funds and large institutions have $1K invested in PAVmed Inc. Warrant in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
0% more capital invested
Capital invested by funds: $1K → $1K ($0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$703 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
|
WAM
2
Wolverine Asset Management
Chicago,
Illinois
| – | +$703 | +688 | New |
|
PAVMW Hedge Fund Activity: Q3 2020 in Review
2 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Warrant (PAVMW) for Q3 2020, worth a combined $1K — unchanged from a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PAVMW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $703.
- 2 institutional investors held PAVmed Inc. Warrant (PAVMW) as of Q3 2020, up from 1 in Q2 2020.
- Funds reported $1K of PAVmed Inc. Warrant stock for Q3 2020, unchanged quarter-over-quarter.
- 1 fund opened new PAVmed Inc. Warrant positions in Q3 2020 and 0 closed out, a net change of +1 holder.
- The largest PAVmed Inc. Warrant buyer in Q3 2020 was Wolverine Asset Management, an estimated $703 added.
Based on aggregated 13F filings for Q3 2020.